Shift in Disparities in HCV Treatment From Interferon to DAA Shift in Disparities in HCV Treatment From Interferon to DAA

Has the move from HCV treatment with interferon-based therapies to direct-acting antivirals resulted in reduced disparity of patients receiving treatment? For what groups do gaps remain?Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news